Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder	Recruiting	Not stated	2025-11-03		NCT06683092

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boston Children's Hospital	238
Children's Hospital Colorado	46
Cystic Fibrosis Foundation	42
Indiana University	297
Johns Hopkins University	579
Massachusetts General Hospital	758
National Jewish Health	31
University of Kansas Medical Center	169
Washington University School of Medicine	475

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Boston Children's Hospital	Boston	United States	20
Children's Hospital Colorado	Aurora	United States	312
Emory University	Atlanta	United States	262
Indiana University	Bloomington	United States	17
Johns Hopkins University	Baltimore	United States	150
Kansas University Medical Center	Kansas City	United States	25
Massachusetts General Hospital	Boston	United States	1015
National Jewish Health	Denver	United States	72
Nemours Children's	Jacksonville	United States	1
Nemours Children's	Wilmington	United States	1
Nemours Children's	Pensacola	United States	1
Nemours Children's	Orlando	United States	1
Seattle Children's Hospital	Seattle	United States	281
University of Alabama at Birmingham	Birmingham	United States	193
University of Michigan	Ann Arbor	United States	538
University of Pittsburgh Medical Center	Pittsburgh	United States	18
University of Texas Southwestern Medical Center	Dallas	United States	18
Washington University at St. Louis	St Louis	United States	2